Welcome to the Kids' Library!

340B Drug Discount Program : information about hospitals that received an eligibility exception as a

United States. Government Accountability Office, author.
Washington, DC : U.S. Government Accountability Office, 2023. 2023

... annual report on progress towards implementation of the American Pandemic Preparedness Plan : a

White House Steering Committee for Pandemic Innovation (U.S.), author.
[Washington, D.C.] : White House Steering Committee for Pandemic Innovation of the National Science and Technology Council, 2022- 2022

Biomedical research : information on federal contributions to remdesivir: report to congressional co

United States. Government Accountability Office, author.
Washington, DC : United States Government Accountability Office, 2021. 2021

COVID-19 : China medical supply chains and broader trade issues

Sutter, Karen M., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

COVID-19 contracting : observations on federal contracting in response to the pandemic : report to c

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2020. 2020

COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges requi

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2021. 2021

COVID-19: federal efforts accelerate vaccine and therapeutic development, but tranparency needed on

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2020. 2020

COVID-19 : international trade and access to pharmaceutical products

Hart, Nina M., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

COVID-19 : remdesivir for hospitalized adults - a living review.

Evidence Synthesis Program (U.S.), author.
Washington, DC : U.S. Department of Veterans Affairs, Health Services Research & Development Service, 2021- 2021

COVID-19 treatments and therapeutics.

Washington, D.C. : U.S. Department of Health and Human Services 2022

Development and regulation of medical countermeasures for COVID-19 (vaccines, diagnostics, and treat

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Innovative data integration and conceptual space modeling for COVID, cancer and cardiac care

Neustein, Amy, author.
London : Academic Press, an imprint of Elsevier, [2022] 2022

National COVID-19 preparedness plan : March 2022

United States. President (2021- : Biden), author.
[Washington, D.C.] : [White House], 2022. 2022

National strategy for the COVID-19 response and pandemic preparedness : January 2021

United States. President (2021- : Biden), author.
[Washington, D.C.] : [White House], 2021. 2021

The PREP Act and COVID-19, part 1 : statutory authority to limit liability for medical countermeasur

Hickey, Kevin J., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Testing, testing, (phase) 1-2-3 : legal considerations for clinical trials of potential COVID-19 vac

Ward, Erin H., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Treatment of COVID-19 : hydroxychloroquine and chloroquine

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Veterans Affairs: use of additional funding for COVID-19 relief : report to congressional committees

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2021. 2021